The research announcement coincided with confirmation of a major new HPAI H5N1 outbreak in Jefferson County, Wisconsin involving more than 3 million birds.
The discussions coincide with Brazil being selected by FAO to host an international meeting on bird flu prevention and control later this year.
The suspension applies to poultry-based animal feed as well, and only feed that has undergone heat treatment proven to eliminate the H5N1 virus will be permitted.
Meanwhile, Brazilian authorities have launched a diplomatic appeal to key trade partners, such as China and the European Union, to lift existing restrictions.
This compensation will only be available to farms located in the officially regulated zones and directly impacted by the disease control efforts during the outbreak period.
The resurgence is expected to renew pressure on South Africa’s agricultural and veterinary systems, especially with the industry still reeling from the effects of last year’s mass culling.
The cancelled contract had funded Moderna’s early-stage development of an H5 avian flu vaccine, which the company says showed “positive interim” results in a study involving 300 healthy adults.
The outbreak, reported on April 16, marks Brazil’s first instance of avian influenza in a commercial poultry setting.
The smaXtec bolus resides in the cow’s reticulum, where it continuously measures internal body temperature with a precision of ±0.018°F.
Although H5N1 remains rare in humans, its detection in cattle has raised alarm among public health experts, prompting calls for closer monitoring of those in direct contact with livestock.